欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0841/002
药品名称Quatriga Elektrolytfri
活性成分
    • Leucine 3.8 g
    • Serine 3.3 g
    • Proline 5.7 g
    • Phenylalanine 2.6 g
    • OLIVE OIL monohydrate 9.5 g
    • Methionine 2.2 g
    • medium-chain triglycerides 11.4 g
    • Lysine 3.4 g
    • Isoleucine 2.5 g
    • Histidine 1.5 g
    • Glycine 5.6 g
    • Glucose monohydrate 127.0 g
    • fish oil, rich in omega 3-acids 5.7 g
    • Arginine 6.1 g
    • Alanine 7.1 g
    • Threonine 2.2 g
    • Valine 3.1 g
    • Tyrosine 0.12 g
    • Tryptophan 0.63 g
    • SOYBEAN OIL monohydrate 11.4 g
    • Taurine 0.5 g
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB 751 74 Uppsala Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
许可日期2009/09/01
最近更新日期2025/01/29
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase